Axsome Therapeutics, Inc.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
AXSM$133.96+1.2%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Table of Contents
| Page | ||
|---|---|---|
| SPECIAL CAUTIONARY NOTICE REGARDING FORWARD-LOOKING STATEMENTS | 3 | |
| PART I | ||
| ITEM 1 | Business | 4 |
| ITEM 1A | Risk Factors | 41 |
| ITEM 1B | Unresolved Staff Comments | 104 |
| ITEM 1C | Cybersecurity | 104 |
| ITEM 2 | Properties | 106 |
| ITEM 3 | Legal Proceedings | 106 |
| ITEM 4 | Mine Safety Disclosures | 106 |
| PART II | ||
| ITEM 5 | Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities | 107 |
| ITEM 6 | Reserved | 108 |
| ITEM 7 | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 109 |
| ITEM 7A | Quantitative and Qualitative Disclosure About Market Risk | 124 |
| ITEM 8 | Financial Statements and Supplementary Data | 124 |
| ITEM 9 | Changes in and Disagreements with Accountants on Accounting and Financial Disclosure | 124 |
| ITEM 9A | Controls and Procedures | 125 |
| ITEM 9B | Other Information | 126 |
| ITEM 9C | Disclosure Regarding Foreign Jurisdictions that Prevent Inspections | 126 |
| PART III | ||
| ITEM 10 | Directors, Executive Officers and Corporate Governance | 127 |
| ITEM 11 | Executive Compensation | 127 |
| ITEM 12 | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters | 127 |
| ITEM 13 | Certain Relationships and Related Transactions and Director Independence | 127 |
| ITEM 14 | Principal Accountant Fees and Services | 127 |
| PART IV | ||
| ITEM 15 | Exhibits and Financial Statement Schedules | 128 |
| Signatures | 136 | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.